Q. The U.S. Food and Drug Administration (FDA) recently approved Lenacapavir. For which disease is this drug indicated?
Answer: C
Notes:
Explanation: Lenacapavir is an injectable medication developed by Gilead Sciences. It has been approved by the FDA under the brand name Yeztugo as a pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 in adults and adolescents weighing at least 35 kg.
Source- IE
